Parr McKnight Wealth Management Group’s Novo Nordisk NVO Stock Holding History

Parr McKnight Wealth Management Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Hold	7,120	–	–	0.04%	186
2026 Q1	$262K	Sell	7,120 -10,795	-60%	-$511K	0.03%	202
2025 Q4	$912K	Sell	17,915 -9,484	-35%	-$485K	0.12%	159
2025 Q3	$1.52M	Buy	27,399 +943	+4%	+$55.2K	0.2%	129
2025 Q2	$1.83M	Buy	26,456 +19,391	+274%	+$1.32M	0.25%	115
2025 Q1	$491K	Hold	7,065	–	–	0.07%	184
2024 Q4	$608K	Buy	+7,065	New	+$764K	0.09%	170

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Parr McKnight Wealth Management Group's NVO Position: Q2 2026 in Review

Parr McKnight Wealth Management Group held its Novo Nordisk (NVO) position steady in Q2 2026 at 7,120 shares worth $341K. The position accounts for 0.04% of the portfolio, ranked #186.

Parr McKnight Wealth Management Group first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.83M in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Parr McKnight Wealth Management Group held 7,120 shares of Novo Nordisk worth $341K as of Q2 2026.
Parr McKnight Wealth Management Group left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.04% of Parr McKnight Wealth Management Group's portfolio in Q2 2026, its #186 holding.
Parr McKnight Wealth Management Group first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
Parr McKnight Wealth Management Group's Novo Nordisk position peaked at $1.83M in Q2 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.